• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[都灵黑色素瘤中心的皮肤黑色素瘤。306例I期患者(1990 - 1991年)的既往数据、组织病理学特征与临床表现的相关性]

[Cutaneous melanoma at the Turin Melanoma Center. Correlations of anamnestic data, histopathologic aspects and clinical picture in 306 stage-I patients (1990-1991)].

作者信息

Castelli F

机构信息

Istituto di Clinica Dermatologica, Università degli Studi di Torino.

出版信息

Minerva Med. 1993 Nov;84(11):615-20.

PMID:8015689
Abstract

The correlation between anamnestic data, histological and clinical features in 306 stage I patients, studied at the Melanoma Centre in Turin during the period 1990-1991, have been analyzed. The somatic features, the distribution by sex and age, clinical findings, histological type, the Clark assessment and Breslow's thickness are reported. In a short interview, patients were asked about when the lesion and its modifications appeared. The patients have shown a low level of information about the risk of malignant melanoma. The answers prove totally unreliable and the comparison between anamnesis and histological picture has not helped to explain the natural history of melanoma. Both men and women with more formal education have been at greater risk for malignant melanoma than those with less education. The authors underline the importance of the public education campaign on early detection of this tumor.

摘要

对1990年至1991年期间在都灵黑色素瘤中心研究的306例I期患者的既往数据、组织学和临床特征之间的相关性进行了分析。报告了身体特征、性别和年龄分布、临床发现、组织学类型、克拉克评估和布雷斯洛厚度。在一次简短的访谈中,询问患者病变及其变化出现的时间。患者对恶性黑色素瘤风险的了解程度较低。答案完全不可靠,既往史与组织学图像之间的比较无助于解释黑色素瘤的自然史。受过更多正规教育的男性和女性患恶性黑色素瘤的风险均高于受教育程度较低者。作者强调了关于早期发现这种肿瘤的公众教育运动的重要性。

相似文献

1
[Cutaneous melanoma at the Turin Melanoma Center. Correlations of anamnestic data, histopathologic aspects and clinical picture in 306 stage-I patients (1990-1991)].[都灵黑色素瘤中心的皮肤黑色素瘤。306例I期患者(1990 - 1991年)的既往数据、组织病理学特征与临床表现的相关性]
Minerva Med. 1993 Nov;84(11):615-20.
2
[Survival analysis in patients with cutaneous malignant melanoma].[皮肤恶性黑色素瘤患者的生存分析]
Srp Arh Celok Lek. 1997 May-Jun;125(5-6):132-7.
3
Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.头颈部黑色素瘤是一种独特的疾病实体吗?一项基于临床登记的对5702例黑色素瘤患者的比较研究。
Br J Dermatol. 2006 Oct;155(4):771-7. doi: 10.1111/j.1365-2133.2006.07455.x.
4
Biology of desmoplastic melanoma: a case-control comparison with other melanomas.促纤维增生性黑色素瘤的生物学特性:与其他黑色素瘤的病例对照比较
J Clin Oncol. 2005 Sep 20;23(27):6739-46. doi: 10.1200/JCO.2005.04.515.
5
Interobserver variation in the histopathologic reporting of key prognostic parameters, particularly clark level, affects pathologic staging of primary cutaneous melanoma.关键预后参数(尤其是克拉克分级)的组织病理学报告中观察者间的差异,会影响原发性皮肤黑色素瘤的病理分期。
Ann Surg. 2009 Apr;249(4):641-7. doi: 10.1097/SLA.0b013e31819ed973.
6
Distribution of clinical-pathological types of cutaneous melanomas and mortality rate in the region of Passo Fundo, RS, Brazil.巴西南里奥格兰德州帕索丰杜地区皮肤黑色素瘤的临床病理类型分布及死亡率
Int J Dermatol. 2007 Jul;46(7):679-86. doi: 10.1111/j.1365-4632.2007.03037.x.
7
Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.25年来皮肤黑色素瘤预后因素与生存率的发展:德国皮肤病学会中央恶性黑色素瘤登记处的分析
Cancer. 2005 Feb 1;103(3):616-24. doi: 10.1002/cncr.20816.
8
Clinical stages of cutaneous malignant melanoma in Bulgaria.保加利亚皮肤恶性黑色素瘤的临床分期
Neoplasma. 2000;47(4):257-60.
9
Exophytic (pedunculated) malignant melanoma--Cleveland Clinic experience.外生性(带蒂)恶性黑色素瘤——克利夫兰诊所的经验
Ann Plast Surg. 1980 Dec;5(6):432-5.
10
[Prospective clinical study on new cutaneous melanomas in the Vendée area].[旺代地区新发皮肤黑色素瘤的前瞻性临床研究]
Ann Dermatol Venereol. 2003 Dec;130(12 Pt 1):1125-8.